President & CEO of Illumina, Inc. (ILMN, Financial) Jay T Flatley sells 5,000 shares of ILMN on 11/23/2012 at an average price of $53.32 a share.
Illumina, Inc. has a market cap of $6.51 billion; its shares were traded at around $51.49 with a P/E ratio of 37.5 and P/S ratio of 6.2. Illumina, Inc. had an annual average earning growth of 35.1% over the past 5 years.
For the complete insider trading history of ILMN, click here.
Illumina, Inc. has a market cap of $6.51 billion; its shares were traded at around $51.49 with a P/E ratio of 37.5 and P/S ratio of 6.2. Illumina, Inc. had an annual average earning growth of 35.1% over the past 5 years.
CEO Recent Trades:
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 11/23/2012 at the average price of 53.32. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 3.43% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 11/08/2012 at the average price of 47.99. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has increased by 7.29% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 10/25/2012 at the average price of 46.78. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has increased by 10.07% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 10/11/2012 at the average price of 51.58. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 0.17% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 09/27/2012 at the average price of 46.87. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has increased by 9.86% since.
Directors and Officers Recent Trades:
- Sr VP & GM Molecular Biology Mark L Lewis sold 5,000 shares of ILMN stock on 11/19/2012 at the average price of 50. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has increased by 2.98% since.
- Sr VP, General Manager Genomic Christian O Henry sold 10,000 shares of ILMN stock on 10/09/2012 at the average price of 51.7. Christian O Henry owns at least 37,745 shares after this. The price of the stock has decreased by 0.41% since.
- Sr VP, General Manager Genomic Christian O Henry sold 30,000 shares of ILMN stock on 09/14/2012 at the average price of 48. Christian O Henry owns at least 37,745 shares after this. The price of the stock has increased by 7.27% since.
- Director Karin Eastham sold 10,000 shares of ILMN stock on 06/01/2012 at the average price of 41.94. Karin Eastham owns at least 6,360 shares after this. The price of the stock has increased by 22.77% since.
For the complete insider trading history of ILMN, click here.
